Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Project: Research project

Project Details

StatusFinished
Effective start/end date5/14/19 → 5/14/22

Funding

  • ICON Clinical Research Limited ((OE) Prot #R475-OA-1816 // (OE) Prot #R475-OA-1816)
  • Regeneron Pharmaceuticals, Inc. ((OE) Prot #R475-OA-1816 // (OE) Prot #R475-OA-1816)